NIKKEI 225
38,835.10 0.00 (0.00%) HANG SENG
18,479.37 -98.93 (-0.53%) CRUDE OIL
78.33 -0.05 (-0.06%) GOLD FUTURES
2,323.30 -0.90 (-0.04%) DOW
38,884.26 +31.99 (+0.08%) Bitcoin GBP
49,916.36 -681.94 (-1.35%)
AstraZeneca PLC (ZEGA.SG)
| Previous close | 70.00 |
| Open | 70.00 |
| Bid | 70.50 x 250000 |
| Ask | 71.00 x 250000 |
| Day's range | 70.00 - 70.50 |
| 52-week range | 56.00 - 71.50 |
| Volume | |
| Avg. volume | 8 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 25 Jul 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Reuters
UPDATE 2-AstraZeneca says it will withdraw COVID-19 vaccine globally as demand dips
AstraZeneca said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a "surplus of available updated vaccines" since the pandemic. The company also said it would proceed to withdraw the vaccine Vaxzevria's marketing authorizations within Europe. "As multiple, variant COVID-19 vaccines have since been developed there is a surplus of available updated vaccines," the company said, adding that this had led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied.
ReutersAstraZeneca says it will withdraw COVID-19 vaccine globally as demand dips
"As multiple, variant COVID-19 vaccines have since been developed there is a surplus of available updated vaccines," the company said, adding that this had led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied. The firm's application to withdraw the vaccine was made on March 5 and came into effect on May 7, according to the Telegraph, which first reported the development. London-listed AstraZeneca began moving into respiratory syncytial virus vaccines and obesity drugs through several deals last year after a slowdown in growth as COVID-19 medicine sales declined.
